Watts, D Heather
Formal Title:
Medical Officer
Responsibilities:
Dr. Watts is responsible for studies of the natural and treated history of HIV infection in women, prevention of HIV infection in women, prevention of mother-to-child transmission of HIV infection, and optimal treatment of pregnant and not-pregnant women
with HIV and other infections such as tuberculosis and malaria.
Email:
wattsh@mail.nih.gov
Address:
6100 Executive Blvd Room 4B11G, MSC 7510
Bethesda Md 20892-7510
For FedEx use:
Rockville Md 20852
Topics in my portfolio:
HIV/AIDS
Women's Health
Vaginitis
Sexually Transmitted Diseases (STDs)
Biosketch:
Dr. Heather Watts, M.D., is a board-certified obstetrician/gynecologist and maternal-fetal medicine specialist who joined the PAMA Branch in July 1998. Dr. Watts is responsible for research activities in the area of HIV infection and its complications among pregnant and non-pregnant women and the prevention of mother-to-child HIV transmission. Dr. Watts led the NICHD-sponsored study of neonatal antiretroviral prophylaxis for prevention of transmission in Brazil, Argentina, Bahamas, the United States, and South Africa, showing that two or three drugs provided to infants born to HIV-infected women who had not received treatment during pregnancy reduced transmission compared to standard zidovudine alone. She participates in development and conduct of clinical trials aimed at reducing perinatal HIV transmission and providing optimal treatment for HIV-infected pregnant women, many of which are conducted by the NICHD and NIAID-funded International Maternal, Pediatric, and Adolescent AIDS Clincial Trials Network (IMPAACT). She serves on the Women's Health Internetwork Scientific Committee of the IMPAACT and Adult AIDS Clinical Trials Group (ACTG) and also advises on several women's health studies in the ACTG. She is the NICHD scientific officer on the Women's Interagency HIV Study, serving on the Executive Committee and several other working groups. She represents NICHD on the Microbicide Trials Network Executive Committee and assists in development of microbicide trials for pregnant women and adolescents. She is the NIH representative to the Antiretroviral Pregnancy Registry and serves on the U.S. guidelines working groups for treatment of HIV-infected pregnant women and prevention of mother to child HIV transmission and on prevention and treatment of opportunistic infections, providing expertise on optimal management of all infections in pregnancy. Dr. Watts also serves on the Health Care for Underserved Women Committee and the HIV Expert Working Group of the American Congress of Obstetricians and Gynecologists. She also serves as an advisor to the NICHD International Site Development Initiative and the Pediatric HIV/AIDS Cohort Study, both of which are led by the Maternal and Pediatric Infectious Disease Branch at NICHD.
Publications (PubMed):
| Title |
Authors |
Publication |
Date |
| Coccidioidomycosis during pregnancy: a review and recommendations for management. | Bercovitch RS,Catanzaro A,Schwartz BS,Pappagianis D,Watts DH,Ampel NM | Clin Infect Dis | 2011 Aug |
| Nelfinavir and Lamivudine pharmacokinetics during the first two weeks of life. | Mirochnick M,Nielsen-Saines K,Pilotto JH,Pinto J,Veloso VG,Rossi S,Moye J,Bryson Y,Mofenson L,Camarca M,Watts DH,NICHD HPTN 040/PACTG 1043 PROTOCOL Team | Pediatr Infect Dis J | 2011 Sep |
| Maternal outcomes after HAART for the prevention of mother-to-child transmission in HIV-infected women in Brazil. | Pilotto JH,Velasque LS,Friedman RK,Moreira RI,Veloso VG,Grinsztejn B,Morgado MG,Watts DH,Currier JS,Hoffman RM | Antivir Ther | 2011 |
| Genital HSV detection among HIV-1-infected pregnant women in labor. | Patterson J,Hitti J,Selke S,Huang ML,Watts DH,Brown Z,Corey L,Wald A | Infect Dis Obstet Gynecol | 2011 |
| Relative time to pregnancy among HIV-infected and uninfected women in the Women's Interagency HIV Study, 2002-2009. | Linas BS,Minkoff H,Cohen MH,Karim R,Cohan D,Wright RL,Young M,Watts DH,Golub ET | AIDS | 2011 Mar 13 |
| Rapid intrapartum or postpartum HIV testing at a midwife obstetric unit and a district hospital in South Africa. | Theron GB,Shapiro DE,Van Dyke R,Cababasay MP,Louw J,Watts DH,Smith E,Bulterys M,Maupin R | Int J Gynaecol Obstet | 2011 Apr |
| Effect of stress and depression on the frequency of squamous intraepithelial lesions. | Massad LS,Agniel D,Minkoff H,Watts DH,D'Souza G,Levine AM,Darragh TM,Young M,Cajigas A,Weber K | J Low Genit Tract Dis | 2011 Jan |
| Birth defects among a cohort of infants born to HIV-infected women on antiretroviral medication. | Watts DH,Huang S,Culnane M,Kaiser KA,Scheuerle A,Mofenson L,Stanley K,Newell ML,Mandelbrot L,Delfraissy JF,Cunningham CK | J Perinat Med | 2011 Mar |
| Bacterial vaginosis: identifying research gaps proceedings of a workshop sponsored by DHHS/NIH/NIAID. | Marrazzo JM,Martin DH,Watts DH,Schulte J,Sobel JD,Hillier SL,Deal C,Fredricks DN | Sex Transm Dis | 2010 Dec |
| Changes in knowledge of cervical cancer prevention and human papillomavirus among women with human immunodeficiency virus. | Massad LS,Evans CT,Weber KM,Goderre JL,Hessol NA,Henry D,Colie C,Strickler HD,Watts DH,Wilson TE | Obstet Gynecol | 2010 Oct |
| Contraceptive efficacy of oral and transdermal hormones when co-administered with protease inhibitors in HIV-1-infected women: pharmacokinetic results of ACTG trial A5188. | Vogler MA,Patterson K,Kamemoto L,Park JG,Watts H,Aweeka F,Klingman KL,Cohn SE | J Acquir Immune Defic Syndr | 2010 Dec |
| Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C. | Brogly SB,Abzug MJ,Watts DH,Cunningham CK,Williams PL,Oleske J,Conway D,Sperling RS,Spiegel H,Van Dyke RB | Pediatr Infect Dis J | 2010 Aug |
| HIV as a risk factor for lung cancer in women: data from the Women's Interagency HIV Study. | Levine AM,Seaberg EC,Hessol NA,Preston-Martin S,Silver S,Cohen MH,Anastos K,Minkoff H,Orenstein J,Dominguez G,Watts DH | J Clin Oncol | 2010 Mar 20 |
| Histologic correlates of glandular abnormalities in cervical cytology among women with human immunodeficiency virus. | Massad LS,Xie X,Darragh TM,Minkoff H,Levine AM,D'Souza G,Cajigas A,Colie C,Watts DH,Strickler HD | Obstet Gynecol | 2009 Nov |
| Knowledge of cervical cancer prevention and human papillomavirus among women with HIV. | Massad LS,Evans CT,Wilson TE,Goderre JL,Hessol NA,Henry D,Colie C,Strickler HD,Levine AM,Watts DH,Weber KM | Gynecol Oncol | 2010 Apr |
| Influence of adherent and effective antiretroviral therapy use on human papillomavirus infection and squamous intraepithelial lesions in human immunodeficiency virus-positive women. | Minkoff H,Zhong Y,Burk RD,Palefsky JM,Xue X,Watts DH,Levine AM,Wright RL,Colie C,D'Souza G,Massad LS,Strickler HD | J Infect Dis | 2010 Mar |
| Risk factors for detectable HIV-1 RNA at delivery among women receiving highly active antiretroviral therapy in the women and infants transmission study. | Katz IT,Shapiro R,Li D,Govindarajulu U,Thompson B,Watts DH,Hughes MD,Tuomala R | J Acquir Immune Defic Syndr | 2010 May 1 |
| Prevalence of HIV among women entering labor who accepted or declined voluntary counseling and testing. | Theron GB,Cababasay MP,Van Dyke RB,Shapiro DE,Louw J,Watts DH,Bulterys M,Styer LM,Maupin R | Int J Gynaecol Obstet | 2012 Nov 8 |
| Antiretrovirals in pregnancy: a note of caution. | Watts DH,Mofenson LM | J Infect Dis | 2012 Dec |
| Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy. | Fife KH,Wu JW,Squires KE,Watts DH,Andersen JW,Brown DR | J Acquir Immune Defic Syndr | 2009 Jul 1 |
| Long-term incidence of cervical cancer in women with human immunodeficiency virus. | Massad LS,Seaberg EC,Watts DH,Minkoff H,Levine AM,Henry D,Colie C,Darragh TM,Hessol NA | Cancer | 2009 Feb 1 |
| Variations in serum müllerian inhibiting substance between white, black, and Hispanic women. | Seifer DB,Golub ET,Lambert-Messerlian G,Benning L,Anastos K,Watts DH,Cohen MH,Karim R,Young MA,Minkoff H,Greenblatt RM | Fertil Steril | 2009 Nov |
| High-grade cervical disease in adolescents with HIV. | Massad LS,Evans CT,D'Souza G,Darragh T,Minkoff H,Henry D,Goparaju L,Muderspach LI,Watts DH | J Low Genit Tract Dis | 2008 Jul |
| Cord blood lipids in infants born to HIV-1-infected women treated with combination antiretroviral therapy. | Melvin AJ,Kang M,Hitti J,Livingston E,Cohn SE,Stocker V,Ross AC,Watts H,McComsey GA | Antivir Ther | 2008 |
| Squamous cervical lesions in women with human immunodeficiency virus: long-term follow-up. | Massad LS,Seaberg EC,Wright RL,Darragh T,Lee YC,Colie C,Burk R,Strickler HD,Watts DH | Obstet Gynecol | 2008 Jun |
| Nevirapine concentrations in newborns receiving an extended prophylactic regimen. | Mirochnick M,Nielsen-Saines K,Pilotto JH,Pinto J,Jiménez E,Veloso VG,Parsons T,Watts DH,Moye J,Mofenson LM,Camarca M,Bryson Y,NICHD/HPTN 040/PACTG 1043 Protocol Team | J Acquir Immune Defic Syndr | 2008 Mar 1 |
| Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093. | Watts DH,Park JG,Cohn SE,Yu S,Hitti J,Stek A,Clax PA,Muderspach L,Lertora JJ | Contraception | 2008 Feb |
| Smoking cessation among women with and at risk for HIV: are they quitting? | Goldberg D,Weber KM,Orsi J,Hessol NA,D'Souza G,Watts DH,Schwartz R,Liu C,Glesby M,Burian P,Cohen MH | J Gen Intern Med | 2010 Jan |
| Retention and attendance of women enrolled in a large prospective study of HIV-1 in the United States. | Hessol NA,Weber KM,Holman S,Robison E,Goparaju L,Alden CB,Kono N,Watts DH,Ameli N | J Womens Health (Larchmt) | 2009 Oct |
| Repeat pregnancies among HIV-infected women enrolled in clinical trial PACTG1022. | Watts DH,Huang S,Cohn SE,Smith L,Hitti J | J Acquir Immune Defic Syndr | 2009 Jun 1 |
| Trends in contraceptive use among women with human immunodeficiency virus. | Sun M,Peipert JF,Zhao Q,Wilson TE,Weber KM,Sanchez-Keeland L,D'Souza G,Young M,Watts DH,Keller MJ,Cohan D,Massad LS | Obstet Gynecol | 2012 Oct |
| Risk of cervical precancer and cancer among HIV-infected women with normal cervical cytology and no evidence of oncogenic HPV infection. | Keller MJ,Burk RD,Xie X,Anastos K,Massad LS,Minkoff H,Xue X,D'Souza G,Watts DH,Levine AM,Castle PE,Colie C,Palefsky JM,Strickler HD | JAMA | 2012 Jul 25 |
| Three postpartum antiretroviral regimens to prevent intrapartum HIV infection. | Nielsen-Saines K,Watts DH,Veloso VG,Bryson YJ,Joao EC,Pilotto JH,Gray G,Theron G,Santos B,Fonseca R,Kreitchmann R,Pinto J,Mussi-Pinhata MM,Ceriotto M,Machado D,Bethel J,Morgado MG,Dickover R,Camarca M,Mirochnick M,Siberry G,Grinsztejn B,Moreira RI,Bastos FI,Xu J,Moye J,Mofenson LM,NICHD HPTN 040/PACTG 1043 Protocol Team | N Engl J Med | 2012 Jun 21 |
| Mother to child transmission of HIV--another complication of bacterial vaginosis? | Watts DH | J Acquir Immune Defic Syndr | 2012 Jul 1 |
| Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants. | Siberry GK,Williams PL,Mendez H,Seage GR 3rd,Jacobson DL,Hazra R,Rich KC,Griner R,Tassiopoulos K,Kacanek D,Mofenson LM,Miller T,DiMeglio LA,Watts DH,Pediatric HIV/AIDS Cohort Study (PHACS) | AIDS | 2012 Jun 1 |
| Effect of human immunodeficiency virus infection on the prevalence and incidence of vaginal intraepithelial neoplasia. | Massad LS,Xie X,Greenblatt RM,Minkoff H,Sanchez-Keeland L,Watts DH,Wright RL,D'Souza G,Merenstein D,Strickler H | Obstet Gynecol | 2012 Mar |
| Correlating knowledge of cervical cancer prevention and human papillomavirus with compliance after colposcopy referral. | Massad LS,Weber KM,Wilson TE,Goderre JL,Hessol NA,Henry D,Colie C,Strickler HD,Levine AM,Watts DH,Evans CT | J Low Genit Tract Dis | 2012 Apr |
| Cervicovaginal human papillomavirus (HPV)-infection before and after hysterectomy: evidence of different tissue tropism for oncogenic and nononcogenic HPV types in a cohort of HIV-positive and HIV-negative women. | D'Souza G,Burk RD,Zhong Y,Minkoff H,Massad LS,Xue X,Watts DH,Anastos K,Palefsky JM,Levine AM,Colie C,Castle PE,Strickler HD | Int J Cancer | 2012 Sep 15 |
| Genital warts and vulvar intraepithelial neoplasia: natural history and effects of treatment and human immunodeficiency virus infection. | Massad LS,Xie X,Darragh T,Minkoff H,Levine AM,Watts DH,Wright RL,D'Souza G,Colie C,Strickler HD,Women's Interagency HIV Study Collaborative Study Group | Obstet Gynecol | 2011 Oct |
| Pharmacokinetics and placental transfer of single-dose tenofovir 1% vaginal gel in term pregnancy. | Beigi R,Noguchi L,Parsons T,Macio I,Kunjara Na Ayudhya RP,Chen J,Hendrix CW,Mâsse B,Valentine M,Piper J,Watts DH | J Infect Dis | 2011 Nov 15 |
| Pharmacokinetics and safety of single-dose tenofovir disoproxil fumarate and emtricitabine in HIV-1-infected pregnant women and their infants. | Flynn PM,Mirochnick M,Shapiro DE,Bardeguez A,Rodman J,Robbins B,Huang S,Fiscus SA,Van Rompay KK,Rooney JF,Kearney B,Mofenson LM,Watts DH,Jean-Philippe P,Heckman B,Thorpe E Jr,Cotter A,Purswani M,PACTG 394 Study Team | Antimicrob Agents Chemother | 2011 Dec |
|
|
|